Stockscreener 앱 받기
0.58%
시간 외 거래:
Mckesson Corporation 주식(MCK)의 최신 뉴스
Jim Cramer on McKesson (MCK): “McKesson Remains a Money Machine” - Insider Monkey
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet - Yahoo Finance
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings? - TradingView
McKesson Reports After Close On 5/8 And Options Expire The Next Day - Forbes
McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 88% of the company - Yahoo Finance
McKesson (MCK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson Careers
McKesson (NYSE:MCK) Declares US$0.71 Dividend Per Share Payable July 2025 - simplywall.st
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
McKesson Corporation Declares Quarterly Dividend - Yahoo Finance
McKesson (MCK) Laps the Stock Market: Here's Why - Yahoo Finance
UBS Adjusts Price Target on McKesson to $805 From $708, Maintains Buy Rating - marketscreener.com
McKesson (MCK) Rises Higher Than Market: Key Facts - Yahoo Finance
Here's What to Expect From McKesson's Next Earnings Report - MSN
McKesson Looks to Improve Precision Oncology Access in Community Practice With New Consortium - Precision Medicine Online
McKesson Corporation (MCK): Among the Growing Dividend Stocks with Low PE Ratios - Insider Monkey
Lobbying Update: $1,220,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed - Nasdaq
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Here's What To Expect From McKesson's Next Earnings Report - Barchart.com
McKesson Shares Rise Nearly 1% After Key SignalMcKesson (NYSE:MCK) - Benzinga
Jim Cramer Reaffirms McKesson (MCK): “One of the Strongest Stocks in the Market” - MSN
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - MSN
McKesson Launches Initiative to Advance Precision Medicine in Community Oncology - Dallas Innovates
McKesson will pay $448,000 for hiring bias against Black, Hispanic and white applicants - MSN
McKesson Announces Launch of Specialty and Infusion for Health Systems - McKesson
McKesson Corporation (MCK): One of the Dividend Stocks with Sustainable Payout Ratios - MSN
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Insider Monkey
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
0.40%
자본화:
|
볼륨(24시간):